Effect of subcellular localization of P21 on proliferation and apoptosis of HepG2 cells

Abstract

This study examined the effect of subcellular localization of P21 on the proliferation and apoptosis of HepG2 cells. The coding genes of the wild and the mutant P21 were amplified by mega primer PCR from the plasmid pCEP-WAF1 which contains human P21 cDNA in the nuclear localizational signal (NLS) sequence, and then inserted into the eukaryotic expression vector pDsRed1-C1. The recombinants were transfected into HepG2 cells. The transcription and expression of P21 were determined by RT-PCR and fluorescence microscopy. The cell proliferation was measured by MTT, and the cell cycle and apoptosis of HepG2 cells by flow cytometry. The results of restriction analysis, DNA sequencing and fluorescence microscopy confirmed the construction of the wild and the mutant P21 in the eukaryotic expression plasmid. The plasmid containing the mutant P21 was found to accelerate cell proliferation and the wild P21 plasmid to inhibit cell proliferation. Cell cycle analysis showed that the cell ratio of G₀/G₁ in the wild type group was significantly increased as compared with that in the mutant type group, and cell apoptosis analysis revealed that the apoptosis rate in the wild type group was much higher than that in the mutant type group. It was concluded that the subcellular localization of P21 may contribute to the development of hepatic cancer.

Keywords

P21 / mega primer PCR / subcellular localization / proliferation / apoptosis

References

[1] ShivjiM.K., GreyS.J., StrausfeldU.P., et al.. Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Curr Biol, 1994, 4(12): 1062-1068

[2] NicholsA.F., SancarA.. Purification of PCNA as a nucleotide excision repair protein. Nucleic Acids Res, 1992, 20(13): 2441-2446

[3] HarrisC.C., HollsteinM.. Clinical implications of the P53 tumor-suppressor gene. N Engl J Med, 1993, 329(18): 1318-1327

[4] GorospeM., CirielliC., WangX., et al.. P21 (Wafl/Cipl) protects against P53-mediated apoptosis of human melanoma cells. Oncogene, 1997, 14(8): 929-935

[5] FanY., BorowskyA.D., WeissR.H.. An antisense oligodeoxynucleotide to P21 (Wafl/Cipl) causes apoptosis in human breast cancer cells. Mol Cancer Ther, 2003, 2(8): 773-782

[6] Pérez-TenorioG., BerglundF., EsguerraM.A., et al.. Cytoplasmic P21WAF1/CIP1 correlates with Akt activation and poor response to tamoxifen in breast cancer. Int J Oncol, 2006, 28(5): 1031-1042

[7] KaoJ.T., ChuahS.K., HuangC.C., et al.. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Liver Int, 2007, 27(6): 772-781

[8] Rodriguez-VilarruplaA., DiazC., CanelaN., et al.. Identification of the nuclear localization signal of P21 (cip1) and consequences of its mutation on cell proliferation. FEBS Lett, 2002, 531(2): 319-323

[9] el-DeiryW.S., TokinoT., VelculescuV.E., et al.. WAF1, a potential mediator of P53 tumor suppression. Cell, 1993, 75(4): 817-825

[10] HarperJ.W., AdamiG.R., WeiN., et al.. The P21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 1993, 75(4): 805-816

[11] NodaA., NingY., VenableS.F., et al.. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res, 1994, 211(1): 90-98

[12] ChildE.S., MannD.J.. The intricacies of P21 phosphorylation: protein/protein interactions, subcellular localization and stability. Cell Cycle, 2006, 5(12): 1313-1319

[13] DongC., LiQ., LyuS.C., et al.. A novel apoptosis pathway activated by the carboxyl terminus of P21. Blood, 2005, 105(3): 1187-1194

[14] BallK.L., LainS., FahraeusR., et al.. Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-teminal domain of P21WAF1. Curr Biol, 1997, 7(1): 71-80

[15] MutohM., LungF.D., LongY.Q., et al.. A P21(Waf1/cip1) carboxyl-teminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells. Cance Res, 1999, 59(14): 3480-3488

[16] LaBaerJ., GarrettM.D., StevensonL.F., et al.. New functional activities for the P21 family of CDK inhibitors. Genes Dev, 1997, 11(7): 847-862

[17] DattaK., BabbarP., SrivastavaT., et al.. P53 dependent apoptosis in glioma cell lines in response to hydrogen peroxide induced oxidative stress. Int J Biochem Cell Biol, 2002, 34(2): 148-157

[18] WagaS.G., HannonJ.D., BeachB., et al.. The P21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 1994, 369(6481): 574-578

[19] TanakaH., YamashitaT., YachiK., et al.. Cytoplasmic P21 (Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats. Neuroscience, 2004, 127(1): 155-164

[20] ChengM., OlivierP., DiehlJ.A., et al.. The P21(cip1) and p27(kip1) CDK “inhibitors” are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J, 1999, 18(6): 1571-1583

[21] AsadaM., YamadaT., IchijoH., et al.. Apoptosis inhibitory activity of cytoplasmic P21 (Cip1/WAF1) in monocytic differentiation. EMBO J, 1999, 18(5): 1223-1234

[22] ManapovF., MullerP., RychlyJ.. Translocation of P21Cip1/WAF1 from the nucleus to the cytoplasm correlates with pancreatic myofibroblast to fibroblast cell conversion. Gut, 2005, 54(6): 814-822

[23] WangZ., BhattacharyaN., MixterP.F., et al.. Phosphoryla tion of the cell cycle inhibitor P21Cip1/WAFT by Pim-1 kinase. Biochim Biophys Acta, 2002, 1593(1): 45-55

[24] ScottM.T., MorriceN., BallK.L.. Reversible phosphorylation at the C-terminal regulatory domain of P21 (Wafl/Cipl) modulates proliferating cell nuclear antigen binding. J Biol Chem, 2000, 75(15): 11529-11537

[25] LloberasJ., CeladaA.. P21 (waf1/CIP1), a CDK inhibitor and a negative feedback system that controls macrophage activation. Eur J Immunol, 2009, 39(3): 691-694

[26] PolvakK., WaldmanT., HeT.C., et al.. Genetic determinants of P53-induced apoptosis and growth arrest. Genes Dev, 1996, 10(15): 1945-1952

[27] SchepersH., GeugienM., EggenB.J., et al.. Constitutive cytoplasmic localization of p21(Waf1/Cip1) affects the apoptotic process in monocytic leukaemia. Leukemia, 2003, 17(11): 2113-2121